IL6 and neoplasm: Young hosts exhibited marked tumour eradication regardless of IL-6 blockade when donor CD4+ T cells were primed with peptide-pulsed DCs, whereas as expected the antitumour effect of CD4+ T cells was impaired in control Ab-treated aged mice.